Lymphomatoid granulomatosis in a patient with rheumatoid arthritis receiving methotrexate: successful treatment with the anti-CD20 antibody mabthera.
Schalk
Enrico
E
Klinik für Hämatologie/Onkologie, Universitätsklinikum Magdeburg, Germany. enrico.schalk@med.ovgu.de
Krogel
Christian
C
Scheinpflug
Katrin
K
Mohren
Martin
M
D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20 / Q000276:immunology; D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D008230:Lymphomatoid Granulomatosis / Q000139:chemically induced* / Q000517:prevention & control*; D008727:Methotrexate / Q000009:adverse effects* / Q000627:therapeutic use*; D000069283:Rituximab; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D007166:Immunosuppressive Agents; D000069283:Rituximab; D008727:Methotrexate